期刊文献+

复方甘草酸苷对暴发性肝衰竭患者的保护作用 被引量:17

Protective effect of Stronger Neo-Minophagen C on patients with fulminant liver failure
暂未订购
导出
摘要 目的:探讨复方甘草酸苷(StrongerNeo-MinophagenC,SNMC)对暴发性肝衰竭(FLF)患者的保护作用.方法:全部病例均为2003-03/2005-03期间住院的患有急性、亚急性重型肝炎的86例实验分为治疗组和对照组.治疗组每天注射(iv)SNMC120mL,同时采用常规保肝支持对症治疗.对照组则仅用保肝支持对症治疗.对比观察两组的转氨酶(ALT)、胆固醇(CHOL)、总胆红素(TBIL)、凝血酶原活动度(PTA)、肿瘤坏死因子-α(TNF-α)、一氧化氮(NO)、白介素-6(IL-6)的变化情况及病情转归.结果:ALT、TBIL两组比较差异不显著(P>0.05);CHOL、PTA在治疗组的恢复程度(3wk后)明显优于对照组,两组差异显著(P<0.01).两组治疗后,治疗组NO、IL-6水平与对照组相比有显著差异(24.5±18.1μmol/Lvs48.1±24.1μmol/L,P<0.01;76.9±71.2ng/Lvs357.1±79.1ng/L,P<0.01).治疗组有17例治疗无效,病死率为37.8%(17/45),对照组有29例治疗无效,病死率为70.7%(29/41),两组相比差异显著(P<0.01).结论:SNMC对暴发性肝衰竭有明显的保护作用,并抑制各种因素所介导的炎症反应,从而防止或缓解肝坏死及减少并发症,降低病死率. AIM: To discuss the protective effect of Stronger Neo-Minophagen C (SNMC) on patients with fulminant liver failure (FLF). METHODS: From March 2003 to March 2005, 86 FLF patients were selected for this study, and they were assigned into group A and B. The patients in group A were intravenously injected with SNMC 120 mL per day, combined with symptomatic treatment to protect the liver. Symptomatic treatment was only performed on patients in group B, serving as controls. The level changes of serum alanine aminotransferase (ALT), cholesterol (CHOL), total bilirubin (TBIL), prothrombin activity (PTA), tumor necrosis factor TNF-α, nitrix oxide (NO), and interleukin-6 (IL-6), as well as the outcome of the disease, were observed and comparatively analyzed. RESULTS: The levels of ALT and TBIL had no significant difference between the two groups (P 〉 0.05), while those of CHOL and PTA were significantly different between them (P 〈 0.01). After treatment, the levels of NO and IL-6 were markedly lower in group A than those in group B (24.5 ± 18.1 μmol/L vs 48.1 ± 24.1 μmol/L, P 〈 0.01; 76.9 ± 71.2 ng/L vs 357.1 ± 79.1 ng/L, P 〈 0.01). The fatality rates were 37.8% (17/45) and 70.7% (29/41), respectively, in group A and B, and there was significant difference between them (P 〈 0.01). CONCLUSION: SNMC has obvious protective effect on FLF patients through inhibiting the inflammation mediated by inflammatory mediators.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第13期1318-1322,共5页 World Chinese Journal of Digestology
基金 黑龙江省十五攻关重大课题 No.200101031-00~~
关键词 甘草酸苷 暴发性肝衰竭 炎症介质 病情转归 Stronger Neo-Hinophagen C Fulminant liver failure Inflammatory mediators Outcome
  • 相关文献

参考文献7

二级参考文献57

  • 1周卫平,张定凤.肝细胞凋亡在暴发性肝炎发病中的作用[J].重庆医科大学学报,1996,21(3):288-290. 被引量:2
  • 2[1]Hentze H, Kunstle G, Volbracht C, et al. CD95mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology, 1999, 30: 177-185.
  • 3[2]Jones JJ, Fan J, Nathens AB, et al. Redox manipulation using the thiol-oxidizing agent dithyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model. Hepatology, 1999, 30: 714-724.
  • 4[3]Jaeschke H, Fisher MA, Lawson JA, et al. Activation of caspase-3 (CPP32)-like proteases is essential for TNF-α induced hepatic parenchymal cell apoptosis and neutrophil mediated necrosis in a murine endotoxin shock model. J Immunol, 1998,160:3480-3486.
  • 5[4]Kunstle G, Hentze H, Germann PG, et al. Concanvalin A hepatotoxi- city in mice. tumor necrosis factor mediated organ failure independent of caspase-3 like protease activation. Hepatology, 1999, 30: 1241-1251.
  • 6[5]Bradharn CA, Palumpe J, Manns MP, et al. Machanisms of hepatic toxicity 1. TNF induced liver injury. Am J Physiol, 1998,275: G387- 392.
  • 7[6]Takahara T, Hayashi N, Tatsumi T, et al. Interleukin-1 beta pro- tects mice from Fas mediated hepatocyte apoptosis and death. Gas- troenterology, 1999,177: 661-668.
  • 8[7]Tsutsui H, Matsui K, Kawada N, et al. IL-18 accounts for both TNF-α and Fas ligand mediated hepatotoxic pathways in endotoxin induced liver injury in mice. J Immunol, 1997,159: 3961-3967.
  • 9[8]Kosai K, Matsamoto K, Nagata S, et al. Abrogation of Fas-mediated FHF in mice by hepatocyte growth factor. Biochem Biophys Res Com- mun, 1998,244:683-690.
  • 10[9]Senaldi G, Shaklee CL, Simen B, et al. Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor induced apop- tosis in vivo and vitro. Hepatology, 1998,27:1584-1591.

共引文献259

同被引文献267

引证文献17

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部